Abstract
Introduction Camrelizumab (also known as SHR-1210), a humanized monoclonal antibody against PD-1, has been shown to block the binding of PD-1 to PD-L1......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
